DrugMapper
  • Browse
    • Therapeutic Area
      • CANCER (51)
      • CARDIOVASCULAR (45)
      • DENTISTRY (2)
      • DERMATOLOGY (31)
      • DIABETES DRUGS & ENDOCRINOLOGY (61)
      • EMERGENCY MEDICINE (3)
      • ENT (5)
      • EYE (23)
      • GASTROINTESTINAL (29)
      • HEMATOLOGY (23)
      • MUSCULOSKELETAL (28)
      • NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
      • PEDIATRICS (27)
      • PHARMACOLOGY (8)
      • PREGNANCY AND GYNECOLOGY (30)
      • RESPIRATORY (42)
      • RHEUMATOLOGY (19)
      • OTHER (1482)
    • Therapeutic Indication
    • Adverse Reaction (System Organ Classification)
    • Mechanism of Action
    • Primary Target
    • Target Level
      • Level 1
      • Level 2
      • Level 3
      • Level 4
      • Level 5
      • Level 6
    • Active Pharmaceutical Ingredients (APIs)
    • Small Molecules
    • ProDrugs
    • Antibodies
    • CNS drugs
    • Metabolites
  • Search
      Therapeutic Indication Adverse Reaction (System Organ Classification)
      Mechanism of Action Target Sequence
      Chemical Structure Physicochemical Properties
  • Analyze

      Networks

    • Chemical Similarity
    • Scaffold Similarity
    • KNIME workflow
  • Downloads
      Web services Bulk Downloads
  • About
      DrugMapper FAQs Data Sources Contact Us

LICORICE

Search structure
Synonyms:
B2048
FEMA NO. 2628
FEMA NO. 2629
FEMA NO. 2630
Glycyrrhiza glabra extract
Glycyrrhiza glabra rhizome
Glycyrrhiza glabra root
Glycyrrhiza glabra root powder
Glycyrrhiza glabra root with rhizome
Licorice
NDI 329
Status: Phase 3
Entry Type: Unknown
Molecule Category: UNKNOWN
UNII: 61ZBX54883

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Dental Caries 2 D003731 ClinicalTrials
Lichen Planus, Oral 2 D017676 ClinicalTrials
Stroke 1 D020521 ClinicalTrials
Mucositis 1 D052016 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109060
FDA SRS 61ZBX54883
CONTENTS
  • Structure
  • Indications
  • Cross References
×
70